What is Global Extra Corporeal Membrane Oxygenation (ECMO) System Market?
The Global Extra Corporeal Membrane Oxygenation (ECMO) System Market is a comprehensive study of the global market trends and growth prospects in the field of ECMO systems. ECMO, or Extra Corporeal Membrane Oxygenation, is a life-saving technique that uses a machine to take over the work of the lungs and sometimes the heart. The system is used in intensive care units to provide life support to patients whose heart and lungs are severely damaged or failing. The ECMO system market is a rapidly growing sector in the global healthcare industry, driven by the increasing prevalence of respiratory and cardiac diseases, technological advancements in ECMO systems, and the growing geriatric population. However, the high cost of ECMO procedures and the risk of complications associated with the use of ECMO systems are some of the factors that may hinder the growth of the market.
Veno-arterial Mode (VA), Veno-venous Mode (VV), Artery-vein Mode (AV) in the Global Extra Corporeal Membrane Oxygenation (ECMO) System Market:
The Global Extra Corporeal Membrane Oxygenation (ECMO) System Market is segmented into Veno-arterial Mode (VA), Veno-venous Mode (VV), and Artery-vein Mode (AV). The VA mode is used when both heart and lung support is needed, while the VV mode is used when only lung support is needed. The AV mode, on the other hand, is used when only heart support is needed. Each mode has its own set of indications, contraindications, complications, and management strategies, which are crucial for the successful application of ECMO therapy. The choice of ECMO mode depends on the patient's condition and the underlying disease.
Hospital, Clinic, Other in the Global Extra Corporeal Membrane Oxygenation (ECMO) System Market:
The Global Extra Corporeal Membrane Oxygenation (ECMO) System Market finds its application in various areas such as hospitals, clinics, and others. In hospitals, ECMO systems are used in intensive care units to provide life support to critically ill patients. In clinics, ECMO systems are used for the treatment of patients with severe respiratory or cardiac failure who are not responding to conventional treatments. Other applications of ECMO systems include research and training purposes. The increasing demand for ECMO systems in these areas is expected to drive the growth of the market.
Global Extra Corporeal Membrane Oxygenation (ECMO) System Market Outlook:
The outlook for the Global Extra Corporeal Membrane Oxygenation (ECMO) System Market is promising. In 2022, the market was valued at US$ 298.1 million and is expected to reach US$ 362.2 million by 2029, growing at a CAGR of 3.3% during the forecast period 2023-2029. The market is predominantly dominated by North America, accounting for 41% of the global market, followed by Europe with a 34% share. The leading players in the market, Medtronic and Maquet, hold more than 50% of the market share. The growth of the market is driven by the increasing prevalence of respiratory and cardiac diseases, technological advancements in ECMO systems, and the growing geriatric population. However, the high cost of ECMO procedures and the risk of complications associated with the use of ECMO systems may hinder the growth of the market.
| Report Metric | Details |
| Report Name | Extra Corporeal Membrane Oxygenation (ECMO) System Market |
| Accounted market size in 2023 | US$ 298.1 million |
| Forecasted market size in 2029 | US$ 362.2 million |
| CAGR | 3.3 |
| Base Year | 2023 |
| Forecasted years | 2023 - 2029 |
| Segment by Type |
|
| Segment by Application |
|
| By Region |
|
| By Company | Medtronic, Nipro, Alung Technologies Inc, Terumo Corporation, Microport Scientific Corporation, Livanova |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
